Registration is open for Oxford Global's 10th Annual Proteins & Antibodies Congress.
- Did you know that experts have estimated that the protein engineering market will be worth $1,463.0 million by 2020?
- Have you heard that much of this growth is expected to come from the advancements in protein & antibody development, novel protein expression approaches as well as improvements in antibody drug conjugates?
Join us for this Congress and discover what opportunities lie in the industry for yourself by networking with over 400 internationally acknowledged VPs, Directors and Heads and other senior level biologics experts and participate in high level scientific discussions on the hottest areas of the proteins & antibodies industry:
Protein & Antibody Development - Join Lorenz Mayr, Vice President, Biological Reagents & Assay Development from AstraZeneca to hear about The Human Secretome Project - A Combination Of Phenotypic And Target-based Drug discovery Strategies
Antibody Engineering - Hear about a case study on how Eli Lilly resolved an engineering problem for bispecific antibodies by Donmienne Leung, Principal Research Scientist, Eli Lilly
Protein Analytics - Discuss Cloning, Expression, Purification & Analytics Of Recombinant Proteins For Drug Discovery with Bohong Zhang, Director & Head of Protein Purification, Shire Pharmaceuticals Inc.
The event also features two new focused protein & antibody biotherapeutics sessions.
If you would like to download the conference programme, which includes the full line up of speakers, please click here.
Hear delegate feedback from our 9th Annual Proteins & Antibodies Congress by viewing our video testimonials.
Further information and registration options:
If you would like further information regarding this congress or information on registration prices, please contact Danielle Dalby today on +44 (0) 1865 248455 or email d.dalby@oxfordglobal.co.uk